Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Enzyme (MLN) vs Anoma (XAN) Price & Performance

Price performance (Past 24H)

Key statistics

Enzyme vs Anoma — how do they compare? Enzyme trades at Rp30,212 (market cap Rp134,13M, Rp104,56M 24h volume), while Anoma trades at Rp190.76 (market cap Rp480,72M, Rp68,85M 24h volume). The key difference: Anoma is far larger — about 3.6× Enzyme's market cap, and Anoma's supply is capped (2,5B / 10B XAN (25%)) while Enzyme's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Enzyme for 29 Days and Anoma for 4 Days on average.

MLNXAN
Market Cap
Rp134,13MRp480,72M
Volume (24h)
Rp104,56MRp68,85M
Circulating Supply
3,3M MLN2,5B / 10B XAN (25%)
Typical Hold Time
29 Days4 Days

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Enzyme

Enzyme (MLN) shows limited market activity with a modest market cap of Rp134,13M and circulating supply of 3,3jt tokens. The asset demonstrates relatively low volatility with an average hold time of 29 days, suggesting stable holder behavior. Trading volumes appear subdued across exchanges, indicating limited speculative interest. No significant protocol upgrades or ecosystem developments have been reported recently, though the project continues to operate its decentralized asset management platform.

Overall outlook remains cautious due to limited liquidity and trading activity. Key opportunities include potential ecosystem growth in decentralized finance asset management, while major risks include low market depth, regulatory uncertainty for DeFi protocols, and competition from larger DeFi platforms. The token's utility within its native protocol remains its primary value driver.

Anoma

Anoma (XAN) currently trades at Rp202.22 with a market cap of Rp507.15M, showing bearish technical signals from moving averages while oscillators remain neutral. The token has 25% circulating supply with 4-day average hold time. Current price sits near the pivot point of Rp197, with immediate resistance at Rp204 and support at Rp191. No major protocol updates or ecosystem developments were identified in recent analysis.

Overall outlook remains cautious with bearish technical momentum outweighing neutral oscillators. Key opportunity lies in potential bounce from support levels, while major risks include low liquidity, limited exchange presence, and typical crypto volatility. Investors should monitor for any ecosystem developments that could drive adoption.

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

MLN

No sentiment data available yet.

XAN
41% Buy59% Sell
Avg holding period · 4 Days

About Enzyme

Enzyme is an easy-to-use on-chain asset management system that enables access to digital assets and DeFi from one simple, unified app. It provides a front-to-back execution and order management system, which provides fully automated reporting, risk management, administration, governance and operations.

Read more on MLN

About Anoma

Anoma is a decentralized operating system that enables developers to build a single app that can run on any blockchain. Its intent-centric architecture simplifies infrastructure complexity, improving development efficiency and user experience. Anoma supports a unified app layer that brings Web3 app functionality closer to Web2 usability.

Read more on XAN